Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.46 CNY 0.27% Market Closed
Market Cap: 98.7B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Shanghai RAAS Blood Products Co Ltd stock under the Base Case scenario is 5.67 CNY. Compared to the current market price of 7.46 CNY, Shanghai RAAS Blood Products Co Ltd is Overvalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
5.67 CNY
Overvaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Shanghai RAAS Blood Products Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Shanghai RAAS Blood Products Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Shanghai RAAS Blood Products Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Shanghai RAAS Blood Products Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Shanghai RAAS Blood Products Co Ltd

Provide an overview of the primary business activities
of Shanghai RAAS Blood Products Co Ltd.

What unique competitive advantages
does Shanghai RAAS Blood Products Co Ltd hold over its rivals?

What risks and challenges
does Shanghai RAAS Blood Products Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shanghai RAAS Blood Products Co Ltd.

Provide P/S
for Shanghai RAAS Blood Products Co Ltd.

Provide P/E
for Shanghai RAAS Blood Products Co Ltd.

Provide P/OCF
for Shanghai RAAS Blood Products Co Ltd.

Provide P/FCFE
for Shanghai RAAS Blood Products Co Ltd.

Provide P/B
for Shanghai RAAS Blood Products Co Ltd.

Provide EV/S
for Shanghai RAAS Blood Products Co Ltd.

Provide EV/GP
for Shanghai RAAS Blood Products Co Ltd.

Provide EV/EBITDA
for Shanghai RAAS Blood Products Co Ltd.

Provide EV/EBIT
for Shanghai RAAS Blood Products Co Ltd.

Provide EV/OCF
for Shanghai RAAS Blood Products Co Ltd.

Provide EV/FCFF
for Shanghai RAAS Blood Products Co Ltd.

Provide EV/IC
for Shanghai RAAS Blood Products Co Ltd.

Show me price targets
for Shanghai RAAS Blood Products Co Ltd made by professional analysts.

What are the Revenue projections
for Shanghai RAAS Blood Products Co Ltd?

How accurate were the past Revenue estimates
for Shanghai RAAS Blood Products Co Ltd?

What are the Net Income projections
for Shanghai RAAS Blood Products Co Ltd?

How accurate were the past Net Income estimates
for Shanghai RAAS Blood Products Co Ltd?

What are the EPS projections
for Shanghai RAAS Blood Products Co Ltd?

How accurate were the past EPS estimates
for Shanghai RAAS Blood Products Co Ltd?

What are the EBIT projections
for Shanghai RAAS Blood Products Co Ltd?

How accurate were the past EBIT estimates
for Shanghai RAAS Blood Products Co Ltd?

Compare the revenue forecasts
for Shanghai RAAS Blood Products Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shanghai RAAS Blood Products Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shanghai RAAS Blood Products Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shanghai RAAS Blood Products Co Ltd compared to its peers.

Compare the P/E ratios
of Shanghai RAAS Blood Products Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shanghai RAAS Blood Products Co Ltd with its peers.

Analyze the financial leverage
of Shanghai RAAS Blood Products Co Ltd compared to its main competitors.

Show all profitability ratios
for Shanghai RAAS Blood Products Co Ltd.

Provide ROE
for Shanghai RAAS Blood Products Co Ltd.

Provide ROA
for Shanghai RAAS Blood Products Co Ltd.

Provide ROIC
for Shanghai RAAS Blood Products Co Ltd.

Provide ROCE
for Shanghai RAAS Blood Products Co Ltd.

Provide Gross Margin
for Shanghai RAAS Blood Products Co Ltd.

Provide Operating Margin
for Shanghai RAAS Blood Products Co Ltd.

Provide Net Margin
for Shanghai RAAS Blood Products Co Ltd.

Provide FCF Margin
for Shanghai RAAS Blood Products Co Ltd.

Show all solvency ratios
for Shanghai RAAS Blood Products Co Ltd.

Provide D/E Ratio
for Shanghai RAAS Blood Products Co Ltd.

Provide D/A Ratio
for Shanghai RAAS Blood Products Co Ltd.

Provide Interest Coverage Ratio
for Shanghai RAAS Blood Products Co Ltd.

Provide Altman Z-Score Ratio
for Shanghai RAAS Blood Products Co Ltd.

Provide Quick Ratio
for Shanghai RAAS Blood Products Co Ltd.

Provide Current Ratio
for Shanghai RAAS Blood Products Co Ltd.

Provide Cash Ratio
for Shanghai RAAS Blood Products Co Ltd.

What is the historical Revenue growth
over the last 5 years for Shanghai RAAS Blood Products Co Ltd?

What is the historical Net Income growth
over the last 5 years for Shanghai RAAS Blood Products Co Ltd?

What is the current Free Cash Flow
of Shanghai RAAS Blood Products Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shanghai RAAS Blood Products Co Ltd.

Business Breakdown

Shanghai RAAS Blood Products Co., Ltd. is a key player in China's biopharmaceutical landscape, specializing in the production and supply of human blood products and diagnostic reagents. Founded in 1992, the company has grown to become one of the largest blood product manufacturers in the country, serving the increasing demand for high-quality and safe blood-derived therapies. The company’s extensive portfolio includes a range of products such as human albumin, immunoglobulins, and coagulants, which are essential for treating various medical conditions, from trauma care to chronic diseases. With a strong commitment to innovation and quality, RAAS has established robust research and developmen...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shanghai RAAS Blood Products Co Ltd

Current Assets 8.2B
Cash & Short-Term Investments 3.4B
Receivables 1.1B
Other Current Assets 3.7B
Non-Current Assets 24.2B
Long-Term Investments 17B
PP&E 1.7B
Intangibles 5.3B
Other Non-Current Assets 132.9m
Current Liabilities 1.6B
Accounts Payable 1.1B
Accrued Liabilities 164.1m
Short-Term Debt 168.4k
Other Current Liabilities 343.5m
Non-Current Liabilities 45.4m
Long-Term Debt 1.5m
Other Non-Current Liabilities 43.9m
Efficiency

Earnings Waterfall
Shanghai RAAS Blood Products Co Ltd

Revenue
8.3B CNY
Cost of Revenue
-5B CNY
Gross Profit
3.3B CNY
Operating Expenses
-954.2m CNY
Operating Income
2.3B CNY
Other Expenses
-543.7m CNY
Net Income
1.8B CNY

Free Cash Flow Analysis
Shanghai RAAS Blood Products Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai RAAS Blood Products Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Operating Income
62/100
Profitability
Score

Shanghai RAAS Blood Products Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai RAAS Blood Products Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Shanghai RAAS Blood Products Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai RAAS Blood Products Co Ltd

Wall Street analysts forecast Shanghai RAAS Blood Products Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai RAAS Blood Products Co Ltd is 6.94 CNY with a low forecast of 6.87 CNY and a high forecast of 7.14 CNY.

Lowest
Price Target
6.87 CNY
8% Downside
Average
Price Target
6.94 CNY
7% Downside
Highest
Price Target
7.14 CNY
4% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Shanghai RAAS Blood Products Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shanghai RAAS Blood Products Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd

Country

China

Industry

Biotechnology

Market Cap

98.7B CNY

Dividend Yield

0.9%

Description

Shanghai RAAS Blood Products Co., Ltd. engages in the research and development, production and sales of blood products. The company is headquartered in Shanghai, Shanghai and currently employs 2,966 full-time employees. The company went IPO on 2008-06-23. The firm's main products include human albumin and human immunoglobulin for intravenous injection, human coagulation factors and others. The firm is also engaged in the distribution of Chinese medicine products and foods. The firm distributes its products within domestic market and to overseas markets.

Contact

SHANGHAI
Shanghai
No. 2009, Wangyuan Road, Fengxian District
+862122130888
www.raas-corp.com

IPO

2008-06-23

Employees

2 966

Officers

GM & Chairman
Mr. Jun Xu
Financial Manager
Mr. Leqi Chen
Deputy GM & Secretary of Board of Directors
Mr. Zheng Liu
Deputy General Manager
Ms. Zhengmin Song
Head of Accounting
Ms. Xi Zhao
Director of Sales & Marketing
Mr. Yang Gu M.D.

See Also

Discover More
What is the Intrinsic Value of one Shanghai RAAS Blood Products Co Ltd stock?

The intrinsic value of one Shanghai RAAS Blood Products Co Ltd stock under the Base Case scenario is 5.67 CNY.

Is Shanghai RAAS Blood Products Co Ltd stock undervalued or overvalued?

Compared to the current market price of 7.46 CNY, Shanghai RAAS Blood Products Co Ltd is Overvalued by 24%.

Back to Top